Article
Involvement of mutation in ampD I, mrcA, and at least one additional gene in β-lactamase hyperproduction in Stenotrophomonas maltophilia.
Antimicrobial agents and chemotherapy - 1 Nov 2013
Talfan Asmaa, Mounsey Oliver, Charman Matthew, Townsend Eleanor, Avison Matthew B
Abstract excerpt
It has been reported that targeted disruption of ampD I or mrcA causes β-lactamase hyperproduction in Stenotrophomonas maltophilia. We show here that β-lactamase-hyperproducing laboratory selected mutants and clinical isolates can have wild-type ampD I and mrcA genes, implicating mutation of at least one additional gene in this phenotype. The involvement of mutations at multiple loci in the activation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
